Annual WinKQCLTM Software Advanced Support for Cat. No. 25-612
Annual WinKQCLTM Software Advanced Support for Cat. No. 25-611
WinKQCLTM 6 Endotoxin Detection and Analysis Software Package fully-integrated, 21CFR part 11 compliant solution for quantitative endotoxin detection analysis, data management, reporting, and trending. (E-delivery)
WinKQCLTM 6 Endotoxin Detection and Analysis Software Package is a fully-integrated, 21CFR part 11 compliant solution for quantitative endotoxin detection analysis, data management, reporting, and trending. (disc copy)
Electronic delivery of the WinKQCLTM 6 Software Workgroup License
E-Delivered copy of the documents used to design, assess risk, test and validate WinKQCLTM 6 Software
Disc copy of the documents used to design, assess risk, test and validate WinKQCLTM 6 Software
Electronic delivery of the WinKQCLTM 6 Software Reader License
-
NK Cell Assay using 3D Bioprinted Tumor ModelsThis white paper describes an ex vivo assay for NK cell killing activity in a 3D bioprinted cervical cancer tumor model.
-
A 3D Bioprinted Model to Study Osteogenic Differentiation of Primary Mesenchymal Stem CellsLearn from this white paper how a 3D bioprinted model using hMSCs can be used for evaluation of bioink compatibility and bioprinting processes.
-
Synthego-Lonza Genome Editing of Resting T cellsCase Study on Genome Editing of Resting T cells
-
3D Natural Killer Cell-mediated Cytotoxicity AssayLonza White Paper
-
WinKQCL™ Endotoxin Detection and Analysis Software - Meeting Your Data Integrity Needs Globally!WinKQCL-Meeting Your Data Integrity Needs.pdf
-
WinKQCL® Software Support OptionsSupport options for WinKQCL® Software
-
The Cell and Gene Therapies Journey from Translation to CommercializationDownload our comprehensive eBook on how to accelerate cell and gene therapy development, from translation to GMP production and commercialization.
-
First siRNA Library Screening in Hard-to-Transfect HUVEC and Jurkat CellsHigh throughput transfection of siRNA libraries has become a valuable tool in target identifi cation and validation. However, such screenings have so far been constrained to mostly easy-totransfect adherent cell lines. Lonza’s 96-well Shuttle® System, based on the well-established Amaxa® Nucleofector® Technology, extends these approaches to primary and diffi cult-to-transfect cells.
-
Transfection of Primary Human HepatocytesEfficient Transfection and Sustained Long Term Functionality
-
Predicting Antibody Dependent Cell-Mediated Cytotoxicity (ADCC)Genotypic and Phenotypic Screening of Human Peripheral Blood Mononuclear Cells